Hepatitis C Virus Envelope Components Alter Localization of Hepatocyte Tight Junction-associated Proteins and Promote Occludin Retention in the Endoplasmic Reticulum
Overview
Authors
Affiliations
Unlabelled: Hepatocyte tight junctions (TJ) play key roles in characteristic liver functions, including bile formation and secretion. Infection by hepatitis C virus (HCV) may cause alterations of the liver architecture and disruption of the bile duct, which ultimately can lead to cholestasis. Herein, we employed the HCV replicon system to analyze the effect of HCV on TJ organization. TJ-associated proteins occludin, claudin-1, and Zonula Occludens protein-1 (ZO-1) disappeared from their normal localization at the border of adjacent cells in Huh7 clones harboring genomic but not subgenomic replicons expressing only the nonstructural proteins. Furthermore, cells containing genomic replicons showed a cytoplasmic accumulation of occludin in the endoplasmic reticulum (ER). TJ-associated function, measured as FITC-dextran paracellular permeability, of genomic replicon-containing cells, was also altered. Interestingly, clearance of the HCV replicon by interferon-alpha (IFN-alpha) treatment and by short hairpin RNA (shRNA) significantly restored the localization of TJ-associated proteins. Transient expression of all HCV structural proteins, but not core protein alone, altered the localization of TJ-associated proteins in Huh7 cells and in clones with subgenomic replicons. Confocal analysis showed that accumulation of occludin in the ER partially co-localized with HCV envelope glycoprotein E2. E2/occludin association was further confirmed by co-immunoprecipitation and pull-down assays. Additionally, using a cell culture model of HCV infection, we observed the cytoplasmic dot-like accumulation of occludin in infected Huh7 cells.
Conclusion: We propose that HCV structural proteins, most likely those of the viral envelope, promote alterations of TJ-associated proteins, which may provide new insights for HCV-related pathogenesis.
Update on Hepatitis C Vaccine: Results and Challenges.
Garbuglia A, Pauciullo S, Zulian V, Del Porto P Viruses. 2024; 16(8).
PMID: 39205311 PMC: 11359353. DOI: 10.3390/v16081337.
Kang J, Lee M, Song J, Choi E, Kim D, Lim S J Microbiol Biotechnol. 2022; 32(12):1583-1588.
PMID: 36453076 PMC: 9843746. DOI: 10.4014/jmb.2209.09026.
DiGuilio K, Rybakovsky E, Abdavies R, Chamoun R, Flounders C, Shepley-McTaggart A Int J Mol Sci. 2022; 23(6).
PMID: 35328419 PMC: 8951934. DOI: 10.3390/ijms23062995.
Immunotherapy for Hepatocellular Carcinoma: New Prospects for the Cancer Therapy.
Fasano R, Shadbad M, Brunetti O, Argentiero A, Calabrese A, Nardulli P Life (Basel). 2021; 11(12).
PMID: 34947886 PMC: 8704694. DOI: 10.3390/life11121355.
Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury.
Wilkinson P, Duncan A Semin Liver Dis. 2021; 41(1):42-49.
PMID: 33764484 PMC: 8056861. DOI: 10.1055/s-0040-1719175.